It is rapidly increasing in incidence over the world. In the USA, the incidence has doubled every 15 years since 1930 to the current rate of 7 per 100,000. In the clear sunny skies of the US southwest, the incidence is 25 per 100,000 which is about the same as in Queensland, Australia.
It is quite clear that early diagnosis results in markedly increased cure rates.
It illustrates the value of both public and professional education, which in Queensland has resulted in cure rates of over 80%.
KeywordsDysplastic Nevus Active Specific Immunotherapy Superficial Spreading Melanoma Acrallentiginous Melanoma Isolation Perfusion
Unable to display preview. Download preview PDF.
References and Further Reading
- Rosenberg RA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Linehan WM, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson CG, White DE (1987) Progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. New Engl J Med 316: 879–905CrossRefGoogle Scholar